ABSTRACT: Weaned pigs often experience growth reduction immediately after weaning due to multiple stress factors associated with weaning. We tested the effect of prenatal and postnatal butyrate supplementation on growth performance of piglets. In study 1, piglets were orally gavaged with 0.3% butyrate from day 4 after birth to weaning (day 21). Butyrate increased ADG by 13% compared to saline treated control. Expression of peroxisome proliferator activated receptor gamma coactivator 1 alpha (PGC-1α) was higher in muscle, adipose tissue, and ileum of butyrate-supplemented animals. Also, peroxisome proliferator activated receptor alpha (PPARα) was induced (P < 0.05) in the subcutaneous adipose tissue (SCAT) and muscle (longissimus dorsi [LD]) of butyrate-supplemented piglets. In vitro, butyrate increased (P < 0.05) fatty acid oxidation in primary adipocytes and suppressed basal lipolysis by 62% compared to untreated cells. Butyrate suppressed (P < 0.05) lipogenesis ( 14 C-glucose incorporation into lipids) in adipocytes. This was accompanied by an approximately 30% reduction in the mRNA expression of fatty acid synthase (P < 0.05) in butyrate-treated cells vs. controls. Piglets born to sows that were supplemented with 0.3% butyrate during the last trimester of gestation had a 15% higher (P < 0.05) body weight at 12 wk than controls. In summary, butyrate supplementation to gestating sows and piglets enhanced postweaning growth performance, which may be mediated by increased substrate oxidation in butyrate treated animals.
INTRODUCTION
The immediate postweaning period often leads to postweaning "growth check" in growing pigs. Antibiotics are used to improve piglet survivability and performance. Antibiotics may lead to development of highly resistant pathogenic strains of bacteria (Thakur et al., 2010) . Butyrate has been shown to have great potential in enhancing piglet health and performance (Kotunia et al., 2004) . Preweaning administration of butyrate to young piglets improves postweaning growth performance and feed conversion effi ciency (Le Gall et al., 2009 ). Rodent models show that butyrate stimulates metabolic adaptation leading to type 1 oxidative muscle fi ber formation and increased fatty acid oxidation via induction of peroxisome proliferator activated receptor gamma (PPARγ) coactivator [peroxisome proliferator activated receptor gamma coactivator 1 alpha (PGC-1α)] expression. It also targets adipose tissue for increased thermogenesis leading to reduced adipose tissue mass. Administration of butyrate during gestation and supplementation of butyrate to piglets during the preweaning and early postweaning periods may lead to permanent epigenetic modifi cations because butyrate suppresses histone deacetylase activity (Gao et al., 2009) . Therefore, we hypothesized that preweaning butyrate administration will increase postweaning piglet performance through activation of oxidative genes in adipose tissue and muscle.
MATERIALS AND METHODS

Supplementation of Gestating Sows with Butyrate
Four parity 1 sows were either assigned to a gestation diet (control) or a gestation diet with 0.3% butyrate supplementation from day 77 of gestation through farrowing and to the end of lactation. The control diet was a corn (Zea mays)-soy (Glycine max) diet with minerals and vitamins supplementation that met the requirements for gestating swine (NRC, 1988) . At farrowing, sows were switched to lactation diets and maintained on the same level of butyrate supplementation as in the gestation diets. Piglets were weaned at 21 d after farrowing and maintained on normal grower diets without additional butyrate supplementation. Piglets were weighed at 12 wk of age.
Postnatal Butyrate Supplementation
Two male piglets of average litter weight were identifi ed from 8 parity 1 litters and assigned to either saline or butyrate supplementation. Butyrate solution (0.3% w/v) in clean water was provided as an oral gavage from 4 d postnatal to weaning (day 21) such that 1 piglet within each litter was assigned to either saline or butyrate treatment. Piglets were orally gavaged twice daily such that each piglet received an average butyrate intake of 500 mg/d. At weaning, 4 piglets on each treatment were killed for tissue analysis and the remaining piglets were raised to 12 wk.
Gene Expression Analysis
Expression of genes involved in fatty acid oxidation [PGC-1α, peroxisome proliferator activated receptor alpha (PPARα), and carnitine palmitoyl transferase 1 alpha (CPT-1α)] and fatty acid synthesis (FAS) was determined by real-time PCR. Genes were normalized to 18s.
In vitro Lipolysis, Fatty Acid Oxidation, and Lipogenesis Assay
Cells were treated with 500 μM of sodium butyrate in all in vitro assays. Rate of fatty acid oxidation in isolated adipocytes was determined as in the presence of 10 μCi/ mL of 3 H-oleate in the absence [control (Con) or presence sodium butyrate for 24 h. Lipolysis was determined from glycerol content in media of cells treated with or without butyrate. Lipogenesis rate was determined in cells challenged with 100 nM insulin and treated with or without sodium butyrate. Lipogenesis was measured as the incorporation of 14 C-glucose into lipids.
Data Analysis
Data are presented as means and SE of treatments. Treatment effect was determined with ANOVA with P value set at 0.05 for signifi cance. Means were compared with Tukey.
RESULTS AND DISCUSSION
Supplementing piglets with butyrate from day 4 after birth increased (P < 0.05) ADG to weaning by 13% compared to saline-treated control pigs (Table 1) . Body 3.01 P < 0.05 1 FAS = fatty acid synthesis; PGC-1α = peroxisome proliferator activated receptor gamma coactivator 1 alpha; ACO = acyl CoA oxidase; CPT-1α = carnitine palmitoyl transferase 1 alpha; PPARα = peroxisome proliferator activated receptor alpha.
2 Fold change relative to saline treatment which was set at 1. 1 PGC-1α = peroxisome proliferator activated receptor gamma coactivator 1 alpha; PPARα = peroxisome proliferator activated receptor alpha.
2 Fold change relative to saline treatment which was set at 1.
weight at 12 wk (day 84) was also higher for butyrate supplemented piglets than control. Piglets from sows supplemented with butyrate during gestation had a higher BW at day 84. The higher BW and ADG of butyrate supplemented pigs and from butyrate-supplemented sows is consistent with the earlier observation by (Le Gall et al., 2009 ) that postweaning weight and feed effi ciency was improved when piglets were supplemented with butyrate before weaning. Butyrate induced (P < 0.05) expression of PGC-1α in subcutaneous adipose tissue (SCAT), longissimus dorsi (LD) muscle, ileum, and liver (Table 2) . Butyrate induced PPARα in adipose tissue and muscle. In isolated adipocytes and muscle explants (Table 3) is consistent with an induction of PGC-1α in adipocyte and muscle explants. In adipocytes, butyrate treatment suppressed (P < 0.05) basal lipolytic rate ( Figure 2A ) and de novo lipogenesis ( Figure 2B ) and stimulated fatty acid oxidation ( Figure 2C ). These data are consistent with the increased expression of PGC-1α and PPARα in the adipose tissue of butyrate-supplemented piglets presented earlier. This confi rms that butyrate favors nutrient partitioning away from adipose tissue. Therefore, butyrate induced metabolic adaptation in adipocytes through downregulation of genes responsible for fatty acid synthesis and upregulation of genes involved in fatty acid oxidation. Therefore, the improved weight gain in butyrate-supplemented piglets may refl ect a metabolic programming by butyrate that enhances energy metabolism, which is ultimately refl ected in higher weight gain.
